|
Gabapentin Clinical Trials
4 actively recruiting trials across 3 locations
Also known as: Gralise, Neurontin
Pipeline
Phase 2: 1Phase 3: 1Phase 1/2: 2
Top Sponsors
- University of Zurich1
- Natalie Lockney1
- Medical University of South Carolina1
- Alliance for Clinical Trials in Oncology1
Indications
- Cancer4
- Cannabis Use Disorder, Mild1
- Bipolar II Disorder1
- Bipolar I Disorder1
- Schizoaffective Disorder, Bipolar Type1
Other1 trial
Phase 1/2
Gilbert, Arizona1 trial
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
Arizona Center for Cancer Care - Gilbert
Phase 3
Charleston, South Carolina1 trial
Gabapentin for Restoring GABA/Glutamate Homeostasis in Co-occurring Bipolar and Cannabis Use Disorders
Medical University Of South Carolina
Phase 2
Nashville, Tennessee1 trial
Gabapentin & Ketamine for Prevention/Treatment of Acute/Chronic Pain in Locally Advanced Head and Neck Cancer
Vanderbilt-Ingram Cancer Center
Phase 1/2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.